RESEARCH

Analysis & Insights

Deep dives on small-cap stocks, scoring methodology, sector analysis, and data-driven market research.

FILTERAll2026Aerospace & DefenseBeginnerChinaConsumer CyclicalCryptoDeep DiveETFsEducationEnergyFundamental AnalysisGovernanceGrowth StocksHealthcareHow-ToIndustrialsMarket AnalysisMetricsMonthly UpdatePortfolio ManagementPortfolio StrategyRankingsRisk ManagementScore AnalysisScoring SystemSector AnalysisSmall-CapStock AnalysisStrategyTechnologyValuationaiapril 2026biotechconsumerearningseducationenergyfda approvalfundamental analysisguidehealthcareindustrialsinvestingmethodologymetricsquarterlyrevenue growthscoringsector analysissmall-capstock analysisstock pickstechnologyvaluationwatchlistweekly
SHOWINGfda approvalClear
fda approvalsmall-caphealthcarebiotechstock analysis

BWAY Gets FDA At-Home Device Approval

BrainSway (BWAY) gets FDA clearance for at-home Deep TMS. Revenue impact, TAM analysis, and score breakdown. Try free for 30 days.